Heparin in acute ischemic stroke revisited
- PMID: 18778842
- DOI: 10.1016/j.neurol.2008.07.014
Heparin in acute ischemic stroke revisited
Abstract
The evidence gathered in clinical trials of low molecular weight heparins (LMWHs) or with unfractionated heparin (UH) given subcutaneously at low or medium doses to patients with acute stroke cannot be extrapolated to the insufficiently tested effects of intravenous, weight-adjusted UH. Recent small studies have provided encouraging results but are potentially confounded and deserve confirmation in larger randomized controlled trials. In accordance with the current understanding of the biology of acute ischemic stroke and the pharmacology of UH, the new randomized controlled trials on heparin should give appropriate credit to the importance of a short therapeutic window, adequate dose adjustment of the drug, intravenous administration, and close monitoring of biological effects. UH is an orphan drug and only an academic driven trial would be able to face such an enterprise. Meanwhile, recommendations against the value of "early" anticoagulation with full dose of weight adjusted UH in the setting of acute ischemic stroke are not based on direct evidence but on extrapolations.
Similar articles
-
Role of heparin and low-molecular-weight heparins in the management of acute ischemic stroke.Expert Rev Cardiovasc Ther. 2006 May;4(3):405-15. doi: 10.1586/14779072.4.3.405. Expert Rev Cardiovasc Ther. 2006. PMID: 16716101 Review.
-
Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.Cerebrovasc Dis. 2008;26(2):171-7. doi: 10.1159/000145324. Epub 2008 Jul 15. Cerebrovasc Dis. 2008. PMID: 18628615 Clinical Trial.
-
Antithrombotic and hypofibrinogenetic therapy in acute ischemic stroke: what is the next step?Cerebrovasc Dis. 2004;17 Suppl 1:138-43. doi: 10.1159/000074806. Cerebrovasc Dis. 2004. PMID: 14694291 Review.
-
ASA or low-molecular-weight heparin in the initial management of acute ischemic stroke complicating atrial fibrillation?CMAJ. 2001 Feb 6;164(3):396. CMAJ. 2001. PMID: 11232150 Free PMC article. No abstract available.
-
The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke.Expert Opin Drug Saf. 2009 Sep;8(5):585-97. doi: 10.1517/14740330903150157. Expert Opin Drug Saf. 2009. PMID: 19614560 Review.
Cited by
-
Unfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage.Neurocrit Care. 2010 Dec;13(3):439-49. doi: 10.1007/s12028-010-9435-1. Neurocrit Care. 2010. PMID: 20809188 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical